We employ
more than 800 technical and support personnel. More than
382 employees work in our Pharmaceutical/Biopharmaceutical
Sciences Division.
Lancaster
Labs has increased our mass spectrometery services and now
offer LTQ-Orbitrap and MALDI-TOF to our ESI-TOF, LC/MS/MS,
LC/MS, ICP/MS and GC/MS capabilities.”
A biosafety
level 3 lab
Cell
banking - Lancaster Labs will house a state-of-the-art
production facility that will provide capabilities to manufacture
and store master and working cell banks.
Viral safety Two new labs will be used to conduct
testing for adventitious agents. These expanded areas
will offer safety for clients’ biopharmaceutical
products.
Viral
clearance studies Two new suites will be available for
clients to conduct scaled-down purification process studies
to validate their manufacturing processes. Lancaster Labs
will provide support for study design as well as analyses
of samples.
